Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data

Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data

Abstract Background A sub-analysis of the Korean population in the LIBERTY ASTHMA QUEST trial (NCT02414854) revealed that dupilumab effectively treated severe uncontrolled asthma. This study aimed to assess the cost-effectiveness of add-on therapy with dupilumab to background therapy in patients ≥ 1...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Sung-Hee Oh, Chin Kook Rhee, Eun Jin Bae, Hyemin Ku
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMC 2024-08-01
Seri Bilgileri:Health Economics Review
Konular:
Asthma
Dupilumab
Cost-effectiveness analysis
Economic evaluation
Quality-adjusted life years
Online Erişim:https://doi.org/10.1186/s13561-024-00532-4

Internet

https://doi.org/10.1186/s13561-024-00532-4

Benzer Materyaller